Schedule 13D ownership disclosure
CYTOMED THERAPEUTICS LIMITED
Ordinary Shares · CUSIP: Y1R80M106
Event date: 2025-10-29
- Filing-level shares
- 2,587,746.00
- Percent of class
- 22.05%
- Choo Chee KongReported CIK 0001970632
Shares: 2,587,746.00 · Class: 22.05%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-020068
- Form type
- SCHEDULE 13D/A
- Filer
- Choo Chee Kong
- CIK
- CIK 1970632
- Filed
- Oct 29, 2025
- Reporting period
- Oct 29, 2025
- Description
- Schedule 13D beneficial ownership